Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
| ▸ | NSD2 | O96028 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 7/20 | 0.35 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | XDH | P47989 | 2/20 | 0.32 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22985267 | 0.95 | KIF11 (0.43) | KIF11PDK2NSD2ARTRPV4 | |
| SCHEMBL22985398 | 0.95 | KIF11 (0.43) | KIF11PDK2NSD2ARTRPV4 | |
| SCHEMBL22985410 | 0.95 | KIF11 (0.41) | KIF11PDK2NSD2ARTRPV4 | |
| SCHEMBL22984983 | 0.94 | KIF11 (0.40) | KIF11PDK2NSD2ARTRPV4 | |
| SCHEMBL22985609 | 0.94 | KIF11 (0.39) | KIF11NSD2ARTRPV4CYP11B2 | |
| SCHEMBL20849138 | 0.93 | KIF11 (0.44) | KIF11PDK2NSD2ARKDM1A | |
| SCHEMBL22985003 | 0.93 | AR (0.43) | KIF11PDK2NSD2ARTRPV4 | |
| SCHEMBL22985022 | 0.93 | KIF11 (0.38) | KIF11PDK2NSD2ARTRPV4 | |
| SCHEMBL22985254 | 0.92 | PDK2 (0.40) | KIF11PDK2ARTRPV4PGR | |
| SCHEMBL22984999 | 0.92 | KIF11 (0.38) | KIF11PDK2ARTRPV4PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919880-B2 | Organic molecules, in particular for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919880-B2 | Organic molecules, in particular for use in optoelectronic devices | OCIAD1, OCIAD2, POU2F1 | KIF11 525/4885PDK2 764/4885NSD2 756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.